Pharma giant, GlaxoSmithkline Consumer Healthcare Ltd has declared that it has bagged final nod from USFDA for Naratriptan Hydrochloride tabs.

The company got nod to sell the tablets in the potencies of 2.5mg base and 1mg base.

Naratriptan hydrochloride pills are prescribed by the physician to put control over migraine attacks in grownups with or without aura.